Table 1.
RVPP (n = 354) | SV (n = 112) | p-Value | |
---|---|---|---|
Age (%) | 0.015 | ||
2–23 months | 187 (52.8) | 74 (66.1) | |
2–5 years | 102 (28.8) | 24 (21.4) | |
6–10 years | 30 (8.5) | 5 (4.5) | |
11–18 years | 35 (9.9) | 9 (8.0) | |
Male sex (%) | 187 (52.8) | 56 (50.0) | 0.47 |
Race/ethnicity (%) | 0.93 | ||
White | 214 (62.8) | 68 (61.2) | |
Black | 67 (19.7) | 16 (15.1) | |
Hispanic | 24 (7.0) | 12 (11.3) | |
Other | 36 (10.6) | 10 (9.4) | |
Comorbidity (%) | |||
Total number, mean (range) | 2.44 (0–8) | 2.69 (0–8) | 0.14 |
Any comorbidity | 314 (88.7) | 95 (84.8) | 0.32 |
Respiratory virus(es) isolated (%) | |||
Adenovirus | 32 (9.0) | 12 (10.7) | 0.58 |
Human metapneumovirus (hMPV) | 40 (11.3) | 0 (0) | <0.0001 |
Human rhinovirus (HRV) | 197 (55.7) | 0 (0) | <0.0001 |
Influenza A | 14 (4.0) | 6 (5.4) | 0.55 |
Influenza B | 10 (2.8) | 3 (2.7) | 0.93 |
Parainfluenza 1 | 3 (0.9) | 11 (9.8) | 0.002 |
Parainfluenza 2 | 6 (1.7) | 3 (2.7) | 0.56 |
Parainfluenza 3 | 23 (6.5) | 8 (7.1) | 0.81 |
Respiratory syncytial virus (RSV) | 77 (21.8) | 62 (55.4) | <0.0001 |
>1 respiratory virus isolated | 45 (12.7) | 0 (0) | <0.0001 |
n = number of patients.